Newron Pharmaceuticals Archives

Home Newron Pharmaceuticals

Latest Posts

News and Trends 6 Jan 2023

Beyond Biotech podcast 28: Mainz Biomed, Newron Pharmaceuticals

This week, we have two guests. We have conversations with Newron CEO, Stefan Weber, and Mainz Biomed CEO, Guido Bächler. Mainz Biomed year-end corporate review Mainz Biomed N.V., a molecular…

January 6, 2023 - 3 minutesmins - By Jim Cornall

Meet some of the biotechs attending Bio-Europe Spring 2023

As Bio-Europe Spring 2023 is set to take place from March 20 to March 22 in Basel, Switzerland, a budding biotech hub, the event will provide opportunities to engage with…

March 10, 2023 - 7 minutesmins - By Roohi Mariam Peter

News and Trends 16 Feb 2023

Newron reports ‘striking’ schizophrenia study results

Newron Pharmaceuticals S.p.A. has announced what it says are ‘very exciting new results’ from the first 100 randomized patients who have completed one year of treatment in its study of…

February 16, 2023 - 5 minutesmins - By Jim Cornall

News and Trends 3 Jan 2023

Newron announces interim results from treatment-resistant schizophrenia trial

Newron Pharmaceuticals S.p.A. has announced what it says are “very compelling new results” from the first 100 enrolled patients to have reached the six-month timepoint in its international study of…

January 3, 2023 - 4 minutesmins - By Jim Cornall

Best in Biotech 10 Oct 2017

Buongiorno Biotech! Top 4 Companies Making Milan Europe’s Next Biotech Hub

Italy may not be the first country that comes to mind when you think of biotech, but the sun is rising in a new dawn for Italian biotechs that are…

October 10, 2017 - 7 minutesmins - By Alex Dale

neurological disorders memory blocking uk

News and Trends 7 Nov 2017

British Researchers Find Thought Police to Treat Neurological Disorders

Cambridge University scientists have identified a chemical in the brain that blocks unwanted thoughts, offering a new avenue to treat neurological disorders. Researchers at the University of Cambridge have found identified a…

November 7, 2017 - 3 minutesmins - By Alex Dale

Stefan Weber CEO Newron Pharmaceuticals Labiotech Meetup Munich

Interview 20 Apr 2017

Newron’s Journey to Launch the First Parkinson’s Drug in 11 Years

Philip talked to Stefan Weber, CEO of Newron Pharmaceuticals, in our first meetup in Munich last week. His company has launched a new drug that could offer many more benefits…

April 20, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 12 May 2017

UPDATE: Italian Pharma receives €11M for Parkinson’s Drug Approval

UPDATE (12/05/2017): Newron has received €11.3M as a milestone payment for the approval from its partner, Zambon, which has the rights to commercialise Xadago globally. Originally published on 21/04/2017 Newron, an…

May 12, 2017 - 2 minutesmins - By Evelyn Warner

Infographics 21 Feb 2017

Infographic: The Biggest Biotech Company in Each European Country

We had a look into European biotech and created a map with the biggest biotech companies in each country, according to their market cap. Biotech is one of the biggest…

February 21, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 11 Oct 2016

World Mental Health Day: How is Biotech Helping the Cause?

Biotech is one of the main forces driving the development of effective therapies to treat neurological and mental disorders. For World Mental Health Day yesterday, we want to share with you some…

October 11, 2016 - 4 minutesmins - By Clara Rodríguez Fernández

News and Trends 8 May 2020

Phase III Failure Sinks Drug for Rare Neurological Disorder

The Italian biotech Newron is halting the development of the experimental drug sarizotan after it failed to meet efficacy endpoints in phase III, dashing hopes for an approved drug for…

May 8, 2020 - 4 minutesmins - By Anita Chakraverty

News and Trends 17 May 2016

New Italian Drug is FDA approved for trials in Rare Neurological Disease

Newron sees its Investigational New Drug application approved by the FDA. It can now begin clinical trials for Rett Syndrome patients - a rare neurological disorder. Based near Milan (Italy), Newron is…

May 17, 2016 - 2 minutesmins - By Denise Neves Gameiro

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Power your event with partnering to deliver attendee ROI. Learn more!

Download Inpart’s latest report

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inpart, the leading platform for biopharma partnering